- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.01. | Pharmadrug Inc (2): Pharmadrug closes acquisition of 19.9% in Canurta | 2 | Stockwatch | ||
| 05.01. | PharmaDrug Inc.: PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring | 198 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,... ► Artikel lesen | |
| 03.11.25 | PharmaDrug To Buy 40% Stake in Canurta, Expanding Botanical Therapeutics Portfolio | 5 | pulse2.com | ||
| 31.10.25 | Pharmadrug Inc (2): Pharmadrug arranges $445,686 debt restructuring | 2 | Stockwatch | ||
| PHARMADRUG Aktie jetzt für 0€ handeln | |||||
| 31.10.25 | PharmaDrug announces debt restructuring | 3 | Seeking Alpha | ||
| 31.10.25 | PharmaDrug Inc.: PharmaDrug Announces Debt Restructuring | 315 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.10.25 | Pharmadrug Inc (2): Pharmadrug firms up deal to acquire 40% of Canurta | 3 | Stockwatch | ||
| 30.10.25 | PharmaDrug signs definitive agreement to acquire equity interest in Canurta | 7 | Seeking Alpha | ||
| 30.10.25 | PharmaDrug Inc.: PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc | 240 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.07.25 | PharmaDrug Inc.: PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc. | 766 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 16.06.25 | PharmaDrug Inc.: PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors | 488 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 06.06.25 | PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value | 417 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,150 | -1,25 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| CANOPY GROWTH | 0,906 | -2,48 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,380 | -2,00 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| INNOCAN PHARMA | 4,280 | +2,88 % | Innocan Pharma Corporation: FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time | HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"),... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 38,150 | -3,78 % | Dermapharm: Spannend für langfristig orientierte Investoren | Am 17. März wird Dermapharm Zahlen für 2025 präsentieren. Erwartet wird von Dermapharm ein Umsatz von 1,16 Milliarden Euro bis 1,2 Milliarden Euro. Das bereinigte EBITDA sieht die Gesellschaft bei 322... ► Artikel lesen | |
| CRONOS GROUP | 2,294 | +1,77 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| VIATRIS | 13,140 | -2,12 % | Viatris Posts Narrower Loss In Q4; Expects Workforce Reduction Of Up To Approx. 10% | WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS) reported a fourth quarter net loss of $340.1 million or $0.30 per share compared to a loss of $516.5 million or $0.43 per share, prior year. The company... ► Artikel lesen | |
| SYNBIOTIC | 2,250 | -3,64 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | -8,33 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,180 | +3,51 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| GREEN THUMB INDUSTRIES | 5,500 | +1,48 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,283 | -0,85 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,823 | +3,92 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,076 | +51,20 % | JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited |
PHARMADRUG INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,001 (-50,00 %) liegt der Kurs bei 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMADRUG INC finden Sie auf Wallstreet Online.